Skip to main content
. 2000 Aug 28;6(9):365–372. doi: 10.1016/S1357-4310(00)01775-5

Table 6.

Viral interference with MHC functions

Function/Activity Gene/Protein Virus Mechanism Refs

Effect on MHC class I E3/19K Adenovirus Binding and retention of class I in ER 1, 11, 32, 33, 42
US3 HCMV Binding and retention of class I in ER 1, 11, 32, 33, 34
US2, US11 HCMV Relocation of heavy chain into ER for degradation 1, 11, 32, 33, 34, 49
m4 MCMV Binds class I molecules 1, 11, 32, 33, 34
m6 MCMV Binding of class I molecules and transport to lysosomes for degradation 1, 11, 32, 33, 34
m152 MCMV Retains class I in ER–Golgi intermediate compartment 1, 11, 32, 33, 34, 35
K3, K5 HHV-8, MHV-68 Downregulation of class I molecules 36, 37, 38
Nef HIV Endocytosis of surface class I and CD4 1, 11, 32, 33, 49
Vpu HIV Destabilization of class I, targets CD4 to proteasome 1, 11, 32, 33, 49
Effect on MHC class II E1A Adenovirus Interferes with class II upregulation (IFN-γ signal transduction cascade) 1, 11, 32, 33
Unknown HSV Interference with class II function 1, 11, 32, 33
Unknown HCMV, MCMV Interference with class II upregulation (IFN-γ signal transduction cascade) 1, 11, 32, 33, 34
US2 HCMV Targets class II DR, DM α chain for degradation 1, 11, 32, 33, 34
ORF14 HSV Class II binding 1, 11, 32, 33
E5, E6 HPV, BPV Interference with class II processing, E5 acidification of endosomes, E6 interaction with AP complex 1, 11, 32, 33
Nef HIV Interference with class II processing 1, 11, 32, 33
Effect on TAP ICP-47 HSV Prevents peptide binding to TAP in cytosol 1, 11, 32, 33
US6 HCMV Prevents peptide transport through TAP pore 1, 11, 32, 33, 34
Effect on antigen processing EBNA-1 EBV A Gly–Ala repeat motif prevents proteasomal degradation 1, 11, 32, 33
pp65 HCMV Modulates processing of another HCMV protein 1, 11, 32, 33, 34
Effect on NK cells UL18, m144, r144 HCMV, MCMV, RCMV Class I homolog, inhibits NK cell lysis 1, 11, 32, 33, 34
MC80 MCV Class I homolog, function unknown 1, 11, 32, 33
UL40 HCMV UL40 peptide causes HLA-E upregulation 39, 40
HHS Vulnerability Disclosure